Purpose: The purpose of this study was to compare the use of complementary therapies (CT) among breast and prostate cancer patients during active cancer treatment. The authors compared use and beliefs about the role of CT in cancer recovery. Methods: A self-report survey was completed by 126 breast cancer patients and 82 prostate cancer patients as part of a multisite research project. The self-report questionnaire inquired about the use of various CTs, sources of information about CT, reasons for using CT, beliefs about the benefits and risks of CT, demographic characteristics, and cancer treatment history. Results: Most of the respondents were older than 50 years, Caucasian, married, had attended or completed college, and were less than 1 year postdiagnosis. Prostate cancer patients were significantly older than the breast cancer patients (P < .001). Several differences emerged between the groups. Compared to the prostate cancer patients, significantly more of the breast cancer patients reported using CT because they wanted to reduce the risk of recurrence (P < .01), play a more active role in recovery (P < .01), help manage stress (P < .01), take a more holistic approach (P < .01), or boost the immune system (P < .01). More of the prostate cancer patients reported using CT to have more control of their recovery (P < .05). The 2 groups also differed significantly (P < .01) on several beliefs about the potential benefits and risks of using CT. Conclusions: Most of the patients in this study had used some form of CT since the time of their diagnosis. Differences among breast and prostate cancer patients with regard to their use of CT during cancer treatment should be considered by oncology professionals who are discussing this topic with their patients.
As many as two thirds of adult cancer patients use some form of complementary therapy (CT) during or following standard medical treatment. Determining prevalence rates of cancer patients' use of CT and making comparisons across studies of CT is difficult because of inconsistent definitions among researchers, patients, and providers of what constitutes a complementary and/or alternative therapy. [1] [2] [3] [4] Generally, the definition of CT focuses on the fact that the methods are used in conjunction with, rather than as a substitute for, conventional cancer treatment. Specifically, for example, CT is defined by the American Cancer Society as "those [methods] that patients use along with conventional medicine" 5 ; this definition of CT was used for the present study. Despite the lack of consistent definition, studies suggest that cancer patients use a variety of CT methods, including exercise, dietary/nutritional therapies, massage, acupuncture, herbs, and prayer/spiritual healing. [6] [7] [8] [9] [10] [11] [12] Some forms of CT have been shown to be effective methods of symptom management for cancer patients, especially in the relief of pain, fatigue, nausea, anxiety, and distress. 13 CT has been particularly popular among women with breast cancer 10, 11, 14 ; the frequency of use among these patients ranges from 28% 15 to 72%. 16 Research suggests that breast cancer patients who employ CT tend to be younger and have higher levels of education and income. 2, 3, 14, 15, 17 In terms of medical parameters, CT use appears to be more common among women with late-stage breast cancer than among those with early-stage cancer. 3, 18 With regard to lifestyle behaviors, regular exercise, not smoking, social integration (eg, involvement in community or religious groups), and support group attendance have all been found to be associated with the use of CT. 7, 18 Finally, a patients' emotional state may influence the use of CT; a few reports suggest that women who employ CT report more symptoms of depression as well as anxiety about cancer recurrence than do nonusers. 15, 19 Women with breast cancer use various forms of CT, including exercise, dietary/nutritional therapies, massage, acupuncture, herbs, and prayer/ spiritual healing. 6, [8] [9] [10] [11] [12] 19, 20 Despite the widespread use of CT, most women do not abandon conventional treatments but rather use CT as a supplement to standard medical care. 11 Several explanations have been proposed to explain the impetus to use CT, including the failure of standard medical care, 8 dissatisfaction with conventional medicine, patients' need for autonomy, hope for cure, the amelioration of side effects and physical distress, boosting the immune system, and improving well-being. 3, 10, 15 Much less is known about CT use among prostate cancer patients. Frequency of CT use among these patients in the United States has been estimated to range between 37% 21 and 43%, 22 but the popularity of various methods is reportedly growing. 23, 24 In a multisite study of more than 1000 prostate cancer patients, prevalence estimates of CT use were 24% for past use and 18% for current use. Similar to findings among breast cancer patients, it was noted in this study of prostate cancer patients that higher levels of education and income, as well as later stage disease, were associated with greater CT use. 23 Most patients using CT believed that it would help them live longer, relieve symptoms, and improve quality of life, and almost half reported that they expected CT to cure disease. The authors of that study warned that perception of benefit among these patients is much higher than scientifically supported and that patients should be educated about the efficacy of CT methods.
Nam et al 25 found that between 28% and 39% of men with prostate cancer used CT. A greater percentage of men who were also attending a support group reported using CT compared to men attending a treatment facility. In this study, men who were disease free after treatment were significantly more likely to be using CT. Of the patients, 24% did not inform the urologist of their use of CTs.
A study of CT use among prostate cancer patients in Canada found that 39% of the men were using some form of CT, the most commonly used forms being herbal supplements (saw palmetto), vitamins (vitamin E), and minerals (selenium). The most common reasons for choosing CT were to boost the immune system and prevent recurrence. A slight majority of the men (58%) had told their physician(s) about their CT use. CT users were more likely than nonusers to delay (9%) or decline (4%) conventional treatment. 26 We did not find any studies that compared patients with different types of cancer with regard to the various aspects of CT use, including reasons for use, sources of information, or attitudes and beliefs about CT. The purpose of this study was to compare the use of CT, reasons for use, and beliefs about CT among prostate and breast cancer patients. We sought to determine whether patients with these 2 types of cancer seek out different types of CT and do so for different reasons. We also sought to identify any differences in attitudes about the use of CT in these 2 groups of cancer patients.
Methods

Sample and Procedures
A sample of breast cancer patients and prostate cancer patients was invited to participate in this study. Patients were recruited at 4 cancer treatment facilities (located in Ohio, New Mexico, California, and Louisiana). Patients were invited to participate if they met the following eligibility criteria: (1) at least 18 years of age, (2) diagnosed with breast or prostate cancer, (3) up to 1 year postdiagnosis, and (4) able to complete the survey (ie, can read and write English and no major physical, neurological, or psychiatric limitations). Data were collected between July 2003 and March 2004. A total of 208 surveys was completed: 126 breast (return rate 66%) and 82 prostate (return rate 56%).
At each of the 4 data collection sites, a site coordinator was responsible for obtaining approval from the Institutional Review Board, identifying eligible patients, and recruiting subjects to the study. Study eligibility was established through review of the patient's medical record and/or consultation with an oncology nurse or physician. Patients were recruited to the study during an outpatient appointment. They were given an overview of the purpose of the study and what participation would involve (ie, completing a survey 1 time, no follow-up). If the patient agreed to participate in the study, the site coordinator obtained written informed consent. The site coordinator then provided the patient with a copy of the survey, along with a stamped envelope addressed to the Behavioral Research Center at the American Cancer Society with which to return the completed survey. Patients were instructed to complete and return the survey within 1 week.
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Measures A survey was developed for this study to assess patients' use of and attitudes toward CTs. In the first section, a list of 44 CT methods was provided; participants were asked, "Do you currently practice any of the following methods?" with possible responses of "Yes," "No," or "I am not familiar with this method" (the list is presented in Table 1 ). In the next section, participants indicated whether they had obtained information about CT from a list of 10 sources, including family members, the media, other survivors, and the Internet (see Table  2 ). Next, respondents indicated their reasons for using CT. In response to the item "I have used complementary therapies because . . . ," they were asked to rate their level of agreement (0 = strongly agree to 5 = strongly disagree), with 13 statements describing a variety of potential reasons (this list is presented in Table  3 ). In the next section, participants indicated their beliefs about the benefits/dangers of using CT. In response to the item "I believe that complementary therapies can . . . ," participants rated their level of agreement (0 = strongly agree to 5 = strongly disagree) with 10 statements describing some potential benefits and dangers of CT (this list is presented in Table 4 ).
Statistical Analyses
Differences between breast and prostate cancer patients on basic medical and demographic variables were evaluated using χ 2 and analysis of variance (ANOVA) analyses. For the purposes of presentation in a table and for some of the statistical analyses, the CT methods were divided into categories that were described in a book on CT published by the American Cancer Society. 5 Associations of CT use with demographic and medical factors (ie, age, race, highest education, marital status, time since diagnosis) were evaluated using χ 2 tests for the breast and prostate cancer patients. Differences between breast and prostate cancer patients in terms of their reasons for using CT, sources of information about CT, and beliefs about the benefits and risks of CT were evaluated using the χ 2 test of independence.
Results
Characteristics of the Sample
Demographic and medical characteristics of the sample are shown in Table 5 . The majority of both the breast cancer patients and the prostate cancer patients were, respectively, Caucasian (87% and 84%), had attended or graduated from college (71% and 65%), and were married or living with a partner (65% and 80%). The average age of the breast cancer patients was 59 years (SD = 12.3) and of the prostate patients, 66 years (SD = 8.3). Significantly more of the prostate cancer patients were at least 60 years of age, as compared to the breast cancer patients (χ 2 = 5.4, P < .001), and significantly more of the prostate patients were married or living with a partner (χ 2 = 5.4, P < .05). The average time since the most recent cancer diagnosis was 5 months for both groups of patients (range, 1-12 months); 74% of breast cancer and 54% of prostate cancer patients were currently receiving some form of treatment. Significantly more of the breast cancer patients reported receiving surgery (χ 2 = 17.6, P < .001) and chemotherapy (χ 2 = 18.0, P < .001) than the prostate cancer patients. Table 1 presents the percentage of breast and prostate cancer patients who reported that they were currently using various forms of CT. It appears that overall, CT use was less common among the prostate cancer patients compared to the breast cancer patients. No specific therapies were being used by most of the prostate patients, but 3 methods-prayer (58%), exercise (64%), and vitamins (63%)-were being used by most of the breast cancer patients. With regard to the 5 CT categories, breast cancer patients reported significantly greater use of mind, body, spirit; manual healing and touch; herbs and vitamins; diet and nutrition; and pharmaceutical and biological methods. With regard to demographic variables, a higher level of education was significantly associated with use of CT; both breast and prostate cancer patients with a higher education level were more likely to use some form of CT (P < .01). No other demographic or medical variables were significantly associated with CT use.
Use of CT Among Breast and Prostate Cancer Patients
Sources of Information About CT
The use of different sources of information about CT by breast and prostate cancer patients is presented in Table 2 . Breast cancer patients most commonly received information from other cancer survivors (55%) and family members or friends (53%); the prostate cancer patients, from health care professionals (38%) and other cancer survivors (34%). In comparing the 2 groups of patients, significantly more breast cancer patients obtained information from family members or friends (P < .01), magazines or books (P < .05), media (P < .01), or other cancer survivors (P < .01).
Reasons and Beliefs
The various reasons for using CT for breast and prostate cancer patients are presented in Table 3 . For breast cancer patients, the most commonly reported reasons were to reduce risk of recurrence (96%), play a more active role in recovery (92%), boost immune system (89%), help manage stress (84%), and give them hope (82%). The most commonly reported reasons for prostate cancer patients were to have more control of recovery (82%), to reduce risk of recurrence (76%), to give them hope (69%), to play a more active role in recovery (66%), or to boost their immune system (63%).
Although most of the patients in both groups reported some of the same reasons for using CT (eg, control physical side effects), several significant differences emerged between the 2 groups. Compared to the prostate cancer patients, significantly more of the breast cancer patients reported using CT because they wanted to reduce the risk of recurrence (P < .01), play a more active role in recovery (P < .01), help manage stress (P < .01), take a more holistic approach (P < .01), or boost the immune system (P < .01). Significantly more of the prostate cancer patients reported using CT to have more control of their recovery (P < .05). The percentages of breast and prostate cancer patients who agreed or strongly agreed with each of the potential benefits and risks of using CT are presented in Table 4 . Compared to the prostate cancer patients, significantly more of the breast cancer patients reported that they believed that CT can reduce side effects (81% vs 52%, P < .001), provide hope (75% vs 59%, P < .01), help people cope (84% vs 62%, P < .01), boost the immune system (54% vs 28%, P < .01), and reduce stress (87% vs 57% P < .001). In contrast, significantly more of the prostate cancer patients (12%) than the breast cancer patients (2%) reported that CT may provide no help at all (P < .01).
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Discussion
This study found significantly higher use of CT among breast cancer patients than among prostate cancer patients, and the patterns of use, reasons for use, and beliefs about CT differed between these 2 groups. The extent to which these differences are gender related (men vs women) is unclear since some differences are likely to result from differences in cancer type and treatment. Any attempt to separate gender-related effects on CT use and beliefs from cancer-type effects is difficult in this study because only these 2 genderspecific cancers were included. It is, however, a common finding in CT research that women are more likely to use CT than are men. 27 In this study, breast cancer patients were more likely to have received chemotherapy, radiotherapy, and immunotherapy than the prostate cancer patients, which is consistent with treatment patterns for these cancers in general. Of the breast cancer patients, 92% had undergone surgery compared to 42% of the prostate cancer patients, and although 43% of the breast cancer patients had received chemotherapy, only 4% of the prostate cancer patients had. Likewise, 79% of the breast cancer patients had received radiotherapy compared to 46% of the prostate cancer patients. The percentages treated with hormonal therapy were similar for both groups.
Age might also account for some differences. The breast cancer patients were on average younger than the prostate cancer patients (mean age of 59 years for breast cancer patients vs 66 years for prostate cancer patients). Although we did not have information about the cancer stage, it is likely that some of the prostate cancer patients had not been treated (but were instead receiving "watchful waiting" care) and would therefore not have physical side effects of treatments. This difference may partially explain why breast cancer patients were more likely than prostate cancer patients to cite "controlling physical side effects (eg, pain)" as a reason for their own use of CT (73% vs 55%). These findings are consistent with a recent study that found that high symptom distress was associated with use of CT, although this factor was modified by gender: men with higher symptom distress scores were almost 3 times more likely to use CT, although this association was not found in the women in the study. 27 Because the study did not include measures of symptom distress or cancer stage, we do not know to what extent these factors affected the findings.
Another factor that might result in differences in CT use between breast and prostate cancer survivors is the question of disclosure that seeking CT might require. One study found that most men avoided disclosing their prostate cancer diagnosis for a number of reasons, including a desire to live a normal life, to not burden others, and to avoid the stigmatization associated with sexual dysfunction. 28 The breast cancer patients were more likely to report using CTs that involved interaction with others than were the prostate cancer survivors, but a difference was seen in all forms of CT reported, including those that would not require disclosure, such as journaling (see Table 1 ).
In this study, the breast cancer patients expect more benefits from CT than the prostate cancer patients do, and they appear to be less skeptical about CT. The prostate cancer patients were more likely than breast cancer patients to believe that in general, using CT "provides false hope" (26% vs 18%, respectively) and less likely to believe that using CT "provides hope" (59% vs 75% of breast cancer patients). Breast cancer patients were more likely than prostate cancer patients to believe that in general, CT could boost the immune system (54% vs 28%), reduce the risk of recurrence (96% vs 76%), and reduce side effects (81% vs 52%).
Differences in the prevalence of certain coping styles between women and men may account for some differences in the use of CTs between breast and prostate cancer patients. An Austrian study found that an active coping style is associated with use of CT. 29 Playing a more active role in treatment and having more control over recovery motivated both breast and prostate cancer survivors. Oddly, "playing a more active role in recovery" was more often cited by the breast cancer patients than the prostate cancer patients (92% vs 66%) as a reason for their own use of CT, but "want more control over recovery" was more common among prostate cancer patients than breast cancer patients (59% vs 82%).
Faith-and spirituality-based CTs were used more frequently by breast cancer patients than prostate cancer patients: 19% of breast cancer patients versus 7% of prostate cancer patients reported using faith healing. Likewise, 58% of breast cancer patients compared to 32% of prostate cancer patients used prayer/ spiritual practice; 19% versus 6%, respectively, used spiritual healing. Nevertheless, current prayer and spiritual practice use was reported by one third of the prostate cancer patients, making it the third most common CT for this group after exercise (46%) and vitamins (37%).
This study was unique compared to other CT studies in being a multisite study of patients currently (or very recently) in treatment. Every effort was made to include a demographically diverse group of cancer patients, although this was not altogether successful in terms of race/ethnicity. Because of the locations of the study sites, the sample probably did not include an optimal number of rural cancer patients. A significant limitation for this article is that only 2 cancer types were studied, each gender specific, and because a cancer diagnosed commonly in both men and women was not included, it is difficult to discern which differences are due to cancer type and treatment and which are due to gender. Also, since the site coordinators who were responsible for data collection also had extensive clinical duties that prevented them from conducting follow-up with patients, our response rates were relatively low; future projects should include follow-up contact with participants to ensure a good response rate. Despite the limitations of this study, it offers important insights regarding the use of CT among women and men with cancer. This information can be useful for practitioners who are discussing this topic with their patients.
